Modulation of acetylcholine release by n
β
P. De Sarno; Dr. E. Giacobini
π
Article
π
1989
π
John Wiley and Sons
π
English
β 718 KB
Since physostigmine (Phy) is presently used in the experimental treatment of Alzheimer disease (AD) patients by means of intracerebral ventricular (i.c.v.) administration, we designed a study to determine the effect of the drug administered by the same route on the cholinergic system of the rat brai